Ulcer News and Research

RSS

Twenty-five million Americans suffer from ulcers. An ulcer is a sore or hole in the lining of the stomach or duodenum (the first part of the small intestine). People of any age can get an ulcer and women are affected just as often as men.

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.

AACN announces recipients of annual research grants

The American Association of Critical-Care Nurses announces the recipients of its annual research grants, with total available funding of $160,000.

8 Apr 2015

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced its plans for the commercialization of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only –CII.

25 Mar 2015

Case Western Reserve professor urges action to eliminate yaws

Half a century ago, a concentrated global effort nearly wiped a disfiguring tropical disease from the face of the earth. Now, says Case Western Reserve's James W. Kazura, MD, it's time to complete the work.

20 Mar 2015

New in vitro study examines benefits of pear-enriched diet on chronic diseases

A new in vitro (test tube) study, "Dietary functional benefits of Bartlett and Starkrimson pears for potential management of hyperglycemia, hypertension and ulcer bacteria Helicobacter pylori while supporting beneficial probiotic bacterial response," was published in the March issue of Food Research International.

20 Mar 2015

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

Diabetics once facing the prospect of amputation to their lower limbs due to the effects of foot ulcers are now back on their feet thanks to a new technology.

18 Mar 2015

Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one."

17 Mar 2015

PUMA project develops innovative device to prevent risk of Pressure Ulcer

The European research project PUMA (Pressure Ulcer Measurement and Actuation) technically coordinated by the Biomechanics Institute has developed an innovative portable and non-invasive device to prevent and early detect the risk of Pressure Ulcer (PU) development and revert its onset for Tetraplegic Spinal Cord Injured (T-SCI) individuals relying on wheelchairs.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

WHO urges affected countries to increase investment in tackling neglected tropical diseases

WHO urges affected countries to scale up their investment in tackling 17 neglected tropical diseases in order to improve the health and well-being of more than 1.5 billion people. This investment would represent as little as 0.1% of current domestic expenditure on health in affected low and middle income countries for the period 2015-2030.

19 Feb 2015

Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Clinicians from the Veterans Affairs Medical Center in Boise, Idaho, will demonstrate that Leaf Healthcare's new, wireless patient monitoring system can significantly improve a caregiver's pressure ulcer prevention processes. Their presentation will take place at the National Pressure Ulcer Advisory Panel Biennial Conference in Orlando, Fla., this week.

19 Feb 2015

Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

According to data presented at the 73rd Annual Scientific Conference of the American College of Foot and Ankle Surgeons, advances in stem cell therapy can significantly improve outcomes for patients with chronic diabetic foot ulcers. Use of stem cells to treat foot problems like diabetic ulcers may speed up the healing process, preventing infection and hospitalization during recovery.

19 Feb 2015

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).

11 Feb 2015

Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

A West Australian team has found evidence that the stomach ulcer bacterium, Helicobacter pylori, is associated with a lower risk of multiple sclerosis (MS), bolstering evidence for the role of the ‘hygiene hypothesis’ in autoimmune disorders.

21 Jan 2015

FDA approves RYTARY for Parkinson's disease treatment

Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication.

8 Jan 2015

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.

30 Dec 2014

Joerns RecoverCare introduces unique mattress coverlet system to support wound care

Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.

21 Dec 2014

Minnesota hospitals prevent patient harms, save $93 million in health spending

Minnesota hospitals and health systems have prevented more than 12,000 patients from being harmed and saved more than $93 million as a result of a reduction in hospital-acquired conditions from 2010-13. Nationwide, hospitals prevented 1.3 million patient harms and saved more than $12 billion in health spending, according to a report issued today by the U.S. Department of Health and Human Services.

3 Dec 2014

University of Melbourne researcher explores impact of living with chronic wounds

People who live with chronic wounds are often disadvantaged financially and emotionally and remain a hidden aspect of our healthcare system.

12 Nov 2014

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field.

7 Nov 2014

Ulcer News and Research

AACN announces recipients of annual research grants

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Case Western Reserve professor urges action to eliminate yaws

New in vitro study examines benefits of pear-enriched diet on chronic diseases

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

PUMA project develops innovative device to prevent risk of Pressure Ulcer

Egalet announces net revenues of $1.9 million for 2014

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

WHO urges affected countries to increase investment in tackling neglected tropical diseases

Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

FDA approves RYTARY for Parkinson's disease treatment

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Joerns RecoverCare introduces unique mattress coverlet system to support wound care

Minnesota hospitals prevent patient harms, save $93 million in health spending

University of Melbourne researcher explores impact of living with chronic wounds

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News